ENTRY       D00275                      Drug
NAME        Cisplatin (JP18/USP/INN);
            Platinol (TN)
PRODUCT     CISPLATIN (WG Critical Care)
            CISPLATIN (WG Critical Care)
  GENERIC   CISPLATIN (Accord Healthcare)
            CISPLATIN (Athenex Pharmaceutical Division)
            CISPLATIN (BluePoint Laboratories)
            CISPLATIN (FOSUN PHARMA USA)
            CISPLATIN (Fresenius Kabi USA)
            CISPLATIN (Gland Pharma Limited)
            CISPLATIN (Sagent Pharmaceuticals)
            CISPLATIN (Teva Parenteral Medicines)
            CISPLATIN (West-Ward Pharmaceuticals Corp)
FORMULA     PtCl2. 2NH3
EXACT_MASS  298.9556
MOL_WEIGHT  300.051
CLASS       Antineoplastic
             DG01679  Platinum compound
            Transporter substrate
             DG02854  SLC22A2 substrate
REMARK      Same as: C06911
            Therapeutic category: 4291
            ATC code: L01XA01
            Product: D00275<JP/US>
EFFICACY    Antineoplastic, Cell growth inhibitor
  DISEASE   Testicular tumors [DS:H00023]
            Ovarian tumors [DS:H00027]
            Bladder cancer [DS:H00022]
COMMENT     platinum compound
            DNA alkylator
TARGET      DNA
METABOLISM  Transporter: SLC22A2 [HSA:6582]
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
OTHER_MAP   map01524  Platinum drug resistance
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XA Platinum compounds
                 L01XA01 Cisplatin
                  D00275  Cisplatin (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Alkylating Agents
               Cisplatin
                D00275  Cisplatin (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D00275  Cisplatin (JP18/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01679  Platinum compound
               D00275  Cisplatin
             Transporter substrate
              DG02854  SLC22A2 substrate
               D00275  Cisplatin
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00275  Cisplatin
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D00275
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00275
DBLINKS     CAS: 15663-27-1
            PubChem: 7847341
            ChEBI: 27899
            PDB-CCD: CPT
            NIKKAJI: J277.914E
ATOM        5
            1   Z   Pt   34.5801  -25.8301
            2   X   Cl   35.9846  -25.8301
            3   X   Cl   34.5743  -27.2286
            4   N0  N    31.9200  -25.8300
            5   N0  N    33.8100  -24.0800
BOND        2
            1     1   2 1
            2     1   3 1
///
